FindTrial
Sign In

Effect of Menopause on cognitive function

Prevalence of cognitive Impairment in menopausal women - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/061790
Enrollment
80
Registered
2024-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Divya Shukla
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: aged 40 to 60 years female

Exclusion criteria

Exclusion criteria: pre-existing neurological conditions( e.g. Alzheimer disease, Parkinson disease) severe mental health conditions ( e.g., schizophrenia , severe depressions) history of cognitive impairment or dementia diagnosis. history of substance abuse or alcoholism. use of medication that could significantly impact cognitive impairment function (e.g., sedative ,antipsychotics0

Design outcomes

Primary

MeasureTime frame
To determine the prevalence and severity of cognitive impairment among menopausal womenTimepoint: 4 Weeks—

Secondary

MeasureTime frame
TO determine the association between cognitive changes among different menopausal phaseTimepoint: 4 Weeks—

Countries

India

Contacts

Public ContactDr Divya Shukla

amity university

pkumar24@amity.edu9878529787

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026